Related Experiment Video
Updated: Mar 22, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
7.8K
Pulmonary hypertension in the elderly: a different disease?
Grégory Berra1, Stéphane Noble2, Paola M Soccal3
1Service de Pneumologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Breathe (Sheffield, England)
|April 12, 2016
Summary
Distinguishing pulmonary hypertension (PH) in elderly patients from normal aging is challenging. This difficulty complicates accurate diagnosis and timely treatment initiation for older adults with PH.
Area of Science:
- Gerontology
- Cardiology
- Pulmonary Medicine
Background:
- Pulmonary hypertension (PH) presents diagnostic challenges, particularly in elderly populations.
- Normal physiological changes associated with aging can mimic or mask PH symptoms.
Purpose of the Study:
- To highlight the diagnostic difficulties in differentiating PH from normal aging in the elderly.
- To emphasize the need for improved diagnostic strategies for PH in geriatric patients.
Main Methods:
- Review of existing literature on PH diagnosis in the elderly.
- Analysis of age-related physiological changes impacting PH presentation.
- Comparison of diagnostic criteria for PH in younger versus older adults.
Main Results:
- The overlap between symptoms of PH and normal aging complicates early and accurate diagnosis.
- Age-related cardiovascular and respiratory changes can obscure the clinical picture of PH.
- Delayed diagnosis of PH in the elderly may lead to poorer outcomes.
Conclusions:
- Accurate differentiation between PH and normal aging is crucial for effective geriatric care.
- Further research is needed to refine diagnostic tools for PH in the elderly.
- Clinical vigilance is essential to avoid misdiagnosis or delayed diagnosis of PH in older individuals.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
820
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
820
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
723
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
723
01:15Drug Dosing: Geriatric Patients
344
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
704
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
704
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
310
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
326
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
326